Philip Low PhD

Philip Low, PhD, a friend of the Medical Devices Group and returning keynote speaker (2016, San Diego), is Chairman, CEO & Founder of NeuroVigil, an international neurotechnology conglomerate with operations in the US, Canada, Europe and soon in the Middle East.

Hia investors include the top law firms in the US, as well as prominent entrepreneurs, from Irwin Jacobs to Elon Musk. His advisors include Nobel Laureates.

Born a Canadian citizen in Vienna, spending early years in Paris and Switzerland, Dr. Low immigrated to the US in the 90s. He has advised four countries, the US Armed Forces, the US Congress and White House, including two US presidents.

He served on the Stanford School of Medicine faculty, had an appointment at MIT, and helped the late Stephen Hawking with his communication needs.

Philip was recognized as one of the Top Young Innovators in the World by MIT, a recognition shared with the founders of Facebook and Google. The Washington Post recognized NeuroVigil as one of the ‘Top 10 Most Innovative Companies in Health Care’ and the Financial Times called his Cambridge Declaration on Consciousness, the first document recognizing consciousness in non-humans, ‘at the leading edge of one of the biggest modern-day shifts in human thought.’

Michelle Sullivan

From her LinkedIn profile: Currently on a mission re Environmental Sustainability. Net zero a must.

20 plus years in Medical devices: sales, management, marketing, Market Development & Market Access.

PG Diploma in Health Economics York University gave me a platform to move into Health Economics, Policy and Reimbursement.

My work in Public Affairs is now linked to my focus on Environmental Sustainability. I chair the ABHI Sustainability group, Vice-chair the Commercial policy group, and sit on the Board of HealthTech Ireland.

Passed course from University of Cambridge course on Business and Climate Change: Towards Net Zero Emissions – Very inspiring!

Stephen Carter

Intellectual Property Works founder Stephen Carter helps innovative start-ups and SMEs put IP at the heart of their business so their IP can be leveraged to support their growth and help them to meet their commercial goals.

He works closely with businesses to help them develop and implement their IP strategies to capture the value in the IP they are developing and to manage the risks presented by IP rights of others, as well as helping them understand the role IP plays in supporting the success of their growing business.

Stephen is a European patent attorney and UK patent attorney with over 20 years of experience working in law firms in London, supporting the IP needs of clients ranging from start-ups to large corporations. Stephen’s ambition in setting up The Intellectual Property Works was to give ambitious start-ups and SMEs access to affordable but high-quality IP advice, tailored to their commercial needs and budgets.

Helena Ting

With a strong academic background and over a decade of industry experience, Lena is extremely well-versed in the business of healthcare.

After stints in consulting and management, she joins her friend Michelle Wu to build Nyquist Data, a SaaS-based portal for intuitive access to FDA,EU, China, Japanese, and clinical trial databases.

It’s a very impressive tool. I (Joe Hage) have seen it in action. My network is blown away by it.

David Tuch

Dr. David Tuch is the Founder and CEO of Lightpoint Medical. He has more than a decade of experience in the medical imaging and pharmaceutical sectors. Previously, he was Head of Research Alliances at GE Healthcare and Head of Clinical Imaging at Novartis. Before joining industry, Dr. Tuch served on the faculty of Harvard Medical School and Massachusetts General Hospital, Department of Radiology. Dr. Tuch holds a PhD from MIT and Harvard Medical School, and a BA from the University of Chicago.

Denis Pasero PhD

Senior scientist, commercialisation leader for solid state batteries; Internet of Things applications

Richard Tuson

Richard writes, “Health Analytical Solutions has over 12 years’ experience in the healthcare sector. Offering unique skills to both NHS & private hospital providers, through to medical device suppliers. The challenging world of healthcare has meant that at HAS we have been able to support many different types of clients through their journey of healthcare.

When approaching the NHS, HAS strategy is to ensure that any interaction moves away from a supplier model, to become more of a long-term solution provider. Whether this is providing capacity from your private hospitals to the NHS or supplying new innovative medical technology, supporting the health and social care act 2012. HAS, therefore, can use their knowledge of both funders commissioning with CCGs and policy experience, to better help medical device companies look at their value proposition and engage at a more meaningful way. Supporting them through the journey.

HAS recognise that change is the constant in health care and navigating it requires the right level of health intelligence. With our skills include data scientists, costing model experts, business case and policy experts, through to implementation and adoption specialists. The whole pathway from end to end is covered. We differ from others because we understand the handshake between each crucial stage. Whether that is the costings of a pathway through to implementation and potential local challenge. We have been there and helped people through the process

The NHS and private hospitals need to embrace new technology. We have been able to make some significant differences By involving all layers of decision-making processes. Ensuring that the solution is resolving the many NHS and private hospital challenges.

The team has worked on many exciting projects from rolling out new services, winning tenders from CCGs to enabling new medical devices to be adopted. Both within the NHS and private hospital groups in the UK. Ultimately providing health and social care benefits to the public.”

Keep in touch!

Ice Cream Social!

Breakfast